A Phase 1 Randomized Blinded Placebo-Controlled Single-Ascending-Dose Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB076 in Healthy Volunteers and Subjects with Alzheimer's Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Alzheimer's disease
  • Age: Between 50 - 80 Years
  • Gender: Male or Female

Inclusion Criteria

Have been diagnosed with mild Alzheimer’s Disease

Do not have any other major health problems

Have someone who can be your study partner (accompany you to certain appointments and provide information about your health)

Are not taking part in another clinical research study with an investigational drug or therapy

Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.